Burning Rock Biotech Ltd. (BNR)
8.33
+0.15
(+1.83%)
USD |
NASDAQ |
Jun 10, 16:00
8.33
0.00 (0.00%)
After-Hours: 20:00
Burning Rock Biotech Enterprise Value : 10.51M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 10.51M |
| June 09, 2026 | 9.195M |
| June 08, 2026 | 17.01M |
| June 05, 2026 | 18.24M |
| June 04, 2026 | 17.80M |
| June 03, 2026 | 13.68M |
| June 02, 2026 | 22.02M |
| June 01, 2026 | 14.03M |
| May 29, 2026 | 19.21M |
| May 28, 2026 | 26.06M |
| May 27, 2026 | 65.68M |
| May 26, 2026 | 88.24M |
| May 22, 2026 | 90.35M |
| May 21, 2026 | 109.44M |
| May 20, 2026 | 113.45M |
| May 19, 2026 | 113.45M |
| May 18, 2026 | 113.45M |
| May 15, 2026 | 117.04M |
| May 14, 2026 | 133.07M |
| May 13, 2026 | 114.08M |
| May 12, 2026 | 114.82M |
| May 11, 2026 | 108.28M |
| May 08, 2026 | 114.08M |
| May 07, 2026 | 112.18M |
| May 06, 2026 | 116.72M |
| Date | Value |
|---|---|
| May 05, 2026 | 116.88M |
| May 04, 2026 | 118.62M |
| May 01, 2026 | 117.62M |
| April 30, 2026 | 116.61M |
| April 29, 2026 | 108.60M |
| April 28, 2026 | 112.92M |
| April 27, 2026 | 138.34M |
| April 24, 2026 | 155.53M |
| April 23, 2026 | 154.48M |
| April 22, 2026 | 157.32M |
| April 21, 2026 | 155.11M |
| April 20, 2026 | 164.71M |
| April 17, 2026 | 155.32M |
| April 16, 2026 | 174.62M |
| April 15, 2026 | 154.16M |
| April 14, 2026 | 147.09M |
| April 13, 2026 | 126.42M |
| April 10, 2026 | 104.43M |
| April 09, 2026 | 108.70M |
| April 08, 2026 | 108.60M |
| April 07, 2026 | 107.02M |
| April 06, 2026 | 109.23M |
| April 02, 2026 | 108.18M |
| April 01, 2026 | 109.23M |
| March 31, 2026 | 107.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 505.29M |
| BioRestorative Therapies, Inc. | 6.124M |
| CareDx, Inc. | 1.040B |
| Natera, Inc. | 30.05B |
| WuXi AppTec Co., Ltd. | 2.782B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.17M |
| Revenue (Quarterly) | 17.81M |
| Total Expenses (Quarterly) | 19.98M |
| EPS Diluted (Quarterly) | -0.2063 |
| Gross Profit Margin (Quarterly) | 78.03% |
| Profit Margin (Quarterly) | -12.18% |
| Earnings Yield | -8.65% |
| Normalized Earnings Yield | -8.651 |